Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Enzymatic synthesis technology of novel cephalo-type anti-infection drug

A technology of enzymatic synthesis and cephalosporins, applied in the direction of fermentation, can solve the problems of unsuitability for industrial production, difficult to find purification methods, and high industrial production costs, and achieve stable and reliable reactions, high product quality, and little environmental pollution.

Active Publication Date: 2015-10-28
SHANDONG LUOXIN PHARMA GRP HENGXIN PHARMA CO LTD
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In the above-mentioned two kinds of processing routes, the synthesis of route one mainly starts from the 7-position of 7-ACA, and route two begins to synthesize from the 3-position of 7-ACA, and route two synthesizes cefzidone yield (71.5 %) is slightly higher than route one (60%), but the weak point of route two is that the by-product of 1-methylthiadiazole-5-mercaptan and 7-ACA reaction is accompanied in the end product always, and it is difficult to Find a suitable purification method, so that its synthesis cost will increase accordingly, which is not suitable for industrial production
[0012] In the prior art method for synthesizing cefazedone sodium, there are generally low yields, poor product color grades and high industrial production costs.
The difficulty of the process leads to the high price of the preparation, which creates an economic burden on the drug users, and the use of highly polluting chemical reagents in the synthesis process causes great damage to the environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enzymatic synthesis technology of novel cephalo-type anti-infection drug
  • Enzymatic synthesis technology of novel cephalo-type anti-infection drug
  • Enzymatic synthesis technology of novel cephalo-type anti-infection drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] (1) Preparation of TDA hydrochloride (TDA·HCl):

[0034] Add 36.5g TDA (Shanghai Yifei Biotechnology Co., Ltd., content: 94.5%, 0.1mol) to 180ml dimethylformamide, stir for 10min, slowly add 20ml of concentrated hydrochloric acid dropwise, finish adding in 30min, adjust the temperature to 25~ React at 30°C for 2 hours; after the reaction, slowly lower the temperature to below 10°C to crystallize for 2 hours, filter, and wash the filter cake with 70ml of acetone for 2 times, and dry it in vacuum at 30-35°C for 3-4 hours to obtain 37.4g of TDA hydrochloride ( TDA·HCl, 0.097mol,), the content is 99.8%, and the molar yield is 98%.

[0035] (2) Preparation of TDA sodium salt (TDA-Na):

[0036]Put 37.4 g of TDA hydrochloride (TDA·HCl, 0.097 mol) obtained in step (1) into a reaction flask, add 160 ml of water, add 17.0 g of sodium bicarbonate in batches under stirring at room temperature to dissolve the solid, filter the reaction solution, and add the filtrate to 300ml of ac...

Embodiment 2

[0040] (1) Preparation of TDA hydrochloride (TDA·HCl):

[0041] Add 38g TDA (Shanghai Yifei Biotechnology Co., Ltd., content 90.3%, 0.1mol) to 200ml isopropanol, stir for 10min, slowly add 38ml concentrated hydrochloric acid dropwise, finish adding in 30min, adjust the temperature to 25~30℃ for reaction 2 hours; after the reaction was completed, the temperature was slowly lowered to below 10°C to crystallize for 1 hour, filtered, and the filter cake was beaten and washed with 70ml of acetone twice, and vacuum-dried at 30-35°C for 3-4 hours to obtain 36.9g of TDA hydrochloride (TDA·HCl , 0.0965mol,), the content is 99.6%, and the molar yield is 96.5%.

[0042] (2) Preparation of TDA sodium salt (TDA-Na):

[0043] Put 36.9 g of TDA hydrochloride (TDA·HCl, 0.0965 mol) obtained in step (1) into a reaction flask, add 200 ml of water, add 17 g of sodium bicarbonate in batches under stirring at room temperature to dissolve the solid, filter the reaction solution, and add the filtrat...

Embodiment 3

[0047] (1) Preparation of TDA hydrochloride (TDA·HCl):

[0048] Add 35g of TDA (Suzhou Vita Chemical Co., Ltd., content: 98.4%, 0.1mol) to 200ml of methanol, stir for 10min, slowly add 18ml of concentrated hydrochloric acid dropwise, finish adding in 30min, adjust the temperature to 30-35°C and react for 1.5 hours; After the reaction is completed, slowly lower the temperature to below 10°C to crystallize for 2 hours, filter, and wash the filter cake with 70ml of acetone twice, and dry it in vacuum at 30-35°C for 3-4 hours to obtain TDA hydrochloride (TDA·HCl, 0.0965mol,) 37g, the content is 99.8%, and the molar yield is 97%.

[0049] (2) Preparation of TDA sodium salt (TDA-Na):

[0050] Put 37g of TDA hydrochloride (TDA·HCl, 0.0965mol) obtained in step (1) into a reaction flask, add 200ml of water, add 17g of sodium bicarbonate in batches under stirring at room temperature to dissolve the solid, filter the reaction solution, add acetone to the filtrate 350ml until turbid, st...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an enzymatic synthesis technology of a novel cephalo-type anti-infection drug. The technology comprises the following steps: preparing TDA hydrochloride from TDA, purifying, processing to prepare TDA sodium salt, and directly carrying out enzymatic synthesis of cefazedone sodium in a water phase under the action of immobilized penicillin acylase. The enzymatic synthesis technology has the advantages of operating step simplification, implementation of a reaction in the water phase, mild reaction conditions, few byproducts, great reduction of energy consumption and organic wastewater discharge, cost reduction, small pollution to environment, good environmental protection property, and industrialization requirement meeting; and the technology greatly improves the product yield and the product yield, the product purity is greater than 99.9%, and the total yield is greater than 90%.

Description

technical field [0001] The invention relates to the field of drug synthesis, in particular to an enzymatic synthesis process of a novel cephalosporin anti-infective drug cefazirone sodium. Background technique [0002] Cefazedone sodium (Cefazedone) belongs to the first generation of injectable cephalosporin antibiotics, and its curative effect on various Gram-positive bacteria and Gram-negative bacteria, including Staphylococcus aureus, Streptococcus, and Enterococcus, is superior to similar drugs— The drug resistance of cefazolin and cephalothin is obviously better than that of the latter. They are classic broad-spectrum antibiotics with broad antibacterial spectrum and wide clinical application. A total of 732 patients in 7 foreign countries and 35 hospitals participated in the clinical research results showed that cefzidome was effective against urinary system infection, respiratory tract infection, surgical-skin infection and gynecological infection caused by gram-posit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P35/04
Inventor 孙松李华路华美
Owner SHANDONG LUOXIN PHARMA GRP HENGXIN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products